TRANSCEND CAPITAL ADVISORS, LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

Back to all holdings Add to watchlist

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
TRANSCEND CAPITAL ADVISORS, LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,246,000
-1.7%
23,590
+14.0%
0.23%
-45.0%
Q2 2020$1,268,000
+8.3%
20,7000.0%0.41%
+17.7%
Q1 2020$1,171,000
+4.4%
20,700
+5.1%
0.35%
+16.2%
Q4 2019$1,122,000–19,700–0.30%–
 Download
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2020
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders